Scarica l'app Stockscreener
16.95
0.94%
-0.16
Dopo l'orario di chiusura:
16.97
0.02
+0.12%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AVTX Giù?
Forum
Previsione
Frazionamento azionario
Avalo Therapeutics Inc Borsa (AVTX) Ultime notizie
Will Avalo Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Retail & Step-by-Step Trade Execution Guides - ulpravda.ru
Will Avalo Therapeutics Inc. stock split attract more investorsEarnings Overview Summary & Risk Controlled Swing Alerts - ulpravda.ru
Moving Averages: Will Avalo Therapeutics Inc. stock split attract more investorsWall Street Watch & Safe Entry Trade Signal Reports - ulpravda.ru
Is Avalo Therapeutics Inc. stock positioned well for digital economy2025 Risk Factors & High Accuracy Swing Trade Signals - ulpravda.ru
Avalo Therapeutics Reports Q3 2025 Financial Results - MSN
Avalo Therapeutics Files $750 Million Mixed Shelf - MarketScreener
What margin trends mean for Avalo Therapeutics Inc. stockSwing Trade & Technical Pattern Based Signals - ulpravda.ru
Is Avalo Therapeutics Inc. stock attractive after correctionPortfolio Risk Summary & Stepwise Entry and Exit Trade Signals - ulpravda.ru
Why analysts remain bullish on Avalo Therapeutics Inc. stockSwing Trade & Fast Gaining Stock Strategy Reports - ulpravda.ru
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
How rising interest rates impact Avalo Therapeutics Inc. stock2025 Trading Recap & Capital Protection Trade Alerts - DonanımHaber
Avalo Therapeutics (NASDAQ:AVTX) Upgraded by Mizuho to "Strong-Buy" Rating - MarketBeat
Will Avalo Therapeutics Inc. (C6K0) stock announce special dividend2025 Market Outlook & Fast Moving Stock Trade Plans - DonanımHaber
Can Avalo Therapeutics Inc. (C6K0) stock survive global slowdownWeekly Stock Summary & Fast Entry Momentum Alerts - DonanımHaber
Breakout Move: Is Avalo Therapeutics Inc. stock a buy on dipsJuly 2025 Macro Moves & Precise Swing Trade Alerts - Улправда
This Valvoline Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Mizuho Initiates Coverage of Avalo Therapeutics (AVTX) with Outperform Recommendation - Nasdaq
Mizuho Initiates Avalo Therapeutics at Outperform With $39 Price Target - marketscreener.com
AVTX: Mizuho Initiates Coverage with Outperform Rating and $39 P - GuruFocus
Mizuho initiates Avalo Therapeutics stock with Outperform rating on HS drug potential By Investing.com - Investing.com South Africa
Mizuho initiates Avalo Therapeutics stock with Outperform rating on HS drug potential - Investing.com Canada
AVTX FinancialsIncome Statement - Quiver Quantitative
EBITDA per share of Avalo Therapeutics Inc – FWB:C6K0 - TradingView — Track All Markets
Avalo Therapeutics Earnings Notes - Trefis
Forecast Cut: How Avalo Therapeutics Inc stock valuations compare to rivalsEarnings Summary Report & Risk Controlled Swing Alerts - moha.gov.vn
Officer Riley Surrenders 637 Of Avalo Therapeutics Inc [AVTX] - TradingView — Track All Markets
Avalo Therapeutics (AVTX) officer discloses employee share transaction details - Stock Titan
Its Stock Has Paid Off Big Time For Avalo Therapeutics Inc - Setenews
With Avalo Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
Why analysts maintain buy rating on Avalo Therapeutics Inc. (C6K0) stockWeekly Risk Report & Reliable Intraday Trade Alerts - Newser
Why Avalo Therapeutics Inc. (C6K0) stock could be next leaderGlobal Markets & Expert Curated Trade Setup Alerts - Newser
Why Avalo Therapeutics Inc. (C6K0) stock stays resilient2025 Support & Resistance & Risk Managed Investment Strategies - Newser
How buybacks impact Avalo Therapeutics Inc. stock value2025 Winners & Losers & Low Risk Investment Opportunities - Newser
Financial Comparison: InMed Pharmaceuticals (NASDAQ:INM) & Avalo Therapeutics (NASDAQ:AVTX) - Defense World
What hedge fund activity signals for Avalo Therapeutics Inc. stockDip Buying & Low Drawdown Trading Techniques - Newser
Is Avalo Therapeutics Inc. (C6K0) stock a top dividend aristocrat candidateNew Guidance & Safe Entry Momentum Tips - Newser
Published on: 2025-12-03 02:49:42 - Newser
Is Avalo Therapeutics Inc. (C6K0) stock overpriced at current multiplesWeekly Market Summary & Low Drawdown Investment Ideas - Newser
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $31.67 Average PT from Analysts - Defense World
Taking the lead: Avalo Therapeutics Inc (AVTX) - setenews.com
How Avalo Therapeutics Inc. stock benefits from strong dollarTrade Exit Summary & AI Based Buy and Sell Signals - Newser
Avalo Therapeutics, Inc. Updates Investor Presentation - TradingView — Track All Markets
Is Avalo Therapeutics Inc. (C6K0) stock resilient in recession scenariosWeekly Risk Summary & Smart Allocation Stock Reports - Newser
What is the fair value of Avalo Therapeutics Inc. stock nowInflation Watch & Risk Controlled Stock Pick Alerts - Newser
How Avalo Therapeutics Inc. (C6K0) stock performs in easing cyclesGap Up & Community Consensus Trade Alerts - Newser
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
HC Wainwright Has Bearish Estimate for AVTX FY2025 Earnings - Defense World
Research Analysts Set Expectations for AVTX FY2025 Earnings - MarketBeat
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):